HA Dermal Filler





- Description
- Benefits
- Shipping & Delivery
-
RICHESSE Premium HA with lidocaine
Cross-linked hyaluronic acid (HA) filler line-up (Soft / Deep / Implant) designed for different skin layers and application areas. Key highlights include biocompatibility, homogeneous monophasic structure, optimized crosslinking, and high-purity manufacturing technology.

Strengths and texture
Excellent biocompatibilitySupports safe procedure implementationHomogeneous cross-linked hyaluronic acid structureMonophasic filler designed for consistent injection feel and stable formulationOptimized crosslinking ratioDesigned for excellent performance with minimal crosslinking rateHigh-purity HA filler manufacturing technologyDesigned to help minimize side effectsThis HA filler is a single-phase, monophasic filler that aims to provide a natural, smooth texture in the treatment area. The formulation is designed to minimize residual BDDE (crosslinking agent), helping reduce swelling and side effects after use and improving overall satisfaction.
Texture guide (Soft / Deep / Implant)
Soft
Deep
ImplantOptimized particle size and application regions
You can apply different lines to different skin layers using distinct HA particle sizes.

Typical application regions by product line (example guide).
SoftLip contour, thin lips, under-eye area, periocular area.DeepMid-forehead, periorbital wrinkles, low nasal bridge, nose tip, nasolabial folds (smile lines).ImplantForehead, cheek area, temple, chin (projection and contouring).

Performance
Wrinkle Improvement Comparison
- Compared to a control product (J*), decomposition characteristics in the body were confirmed to be comparable.
- Wrinkle improvement effect was confirmed when applied in the body, supporting filler performance.
* Examination institution: Gu Se-kwang, professor at Daegu Oriental Medical University.Crosslinking Rate (MoD) Comparison
- Comparative analysis results across three products (excluding).
- Lower crosslinking rate is closer to natural hyaluronic acid properties, supporting safety.
* Testing institution: Korea Institute of Polymer Testing Co., Ltd. (international accredited).Viscoelasticity
- Elastic coefficient (G’) indicates wrinkle-improvement-related performance and shows superior results compared to other products.
- Standardized processing aims to minimize batch variations in hydrogel rheology (G’ / G’’) for consistent handling and performance.
* Based on comparative results with other products.
Endotoxin and BDDE Residue
- Endotoxin was detected below the standard amount.
- BDDE residue was not detected, supporting safety confirmation.
RICHESSE Hyaluronic Acid Dermal FillerSpecification and line up
Analysis Value Specification Analytical method Appearance Complies Colorless, transparent and viscous liquid [In house] Net content > 1.0 mL More than 1.0 mL [In house] pH pH 6.9 pH 6.0 ~ pH 8.0 [KP] Hyaluronic acid identification Complies Red or reddish purple [KPC] Hyaluronic acid assay 24.1 mg/mL 21.6 ~ 26.4 mg/mL [KP] Heavy metals < 2.0 ppm Not more than 2.0 ppm [KP] Osmolality 310 mOsmol/kg 250 ~ 350 mOsmol/kg [In house] Residue of BDDE N.D (Not detected) Not more than 2.0 ppm [KP] Injection force < 40 N Not more than 40 N [In house] Endotoxin < 0.5 EU Not more than 0.5 EU/g [KP] Sterility Complies No growth [In house] HA filler provides a variety of formulations depending on the application and location.
Model Contents
(dosage / lidocaine content)Injection site Needle size
(Gauge)Application Soft 1 mL / 0.3% Middle dermis 30G Superficial fine lines Deep 1 mL / 0.3% Deep dermis 27G Deep lines Implant 1 mL / 0.3% Subcutaneous / supraperiosteal layer 25G Volume augmentation * Disposable, sterile medical devices. Do not reuse.

